Holodoxa • 119 implied HN points • 15 Jan 24
- Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare autosomal dominant disorder caused by germline mutations in the tumor suppressor gene MEN1. Menin, encoded by MEN1, is a scaffold protein involved in various cell functions.
- Genetic discovery of MEN1 led to a better understanding of the disease and enabled precision medicine strategies for patients with MEN1 mutations.
- Therapeutic options for MEN1 include targeted therapies like somatostatin analogues and mTOR inhibitors, as well as chemotherapies; advancements in understanding menin function have opened up potential novel therapeutic approaches.